Soup Recall Update as FDA Sets Highest Risk Level
A soup mix recall issued this month has been updated by the U.S. Food and Drug Administration (FDA) as a Class I risk, the ...
Seafood Recall Update As FDA Sets Risk Level
The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...
FDA Expands Carrot Recall Linked to E. Coli: 39 Illnesses, 15 Hospitalizations Reported
The FDA expanded the recall on November 21 after 39 cases of illness, resulting in 15 hospitalizations and one death, have ...
pharmaphorum6 小时
FDA probing cancer cases with Bluebird's CALD gene therapy
The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...
BioSpace6 天
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster ...
Drinking Water Recall Update as FDA Changes Status
The U.S. Food and Drug Administration (FDA) terminated a recall for Berkeley Club Beverages water on November 13 and recently ...
STAT9 天
The FDA’s risky action on compounding weight loss drugs
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
Dietary Supplement Recall Update As FDA Sets Risk Level
A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
The American Journal of Managed Care3 天
FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs
In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...
Exclusive: Thousands turn to Wegovy copies each month as FDA considers shortage status
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
BioSpace6 天
Merck’s Former Asthma Blockbuster Singulair Could Be Linked to Mental Health Problems ...
A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma ...
Cure Today8 天
The FDA Approves Labeling Update for Sandoz in the Treatment of B-Cell CLL
The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia.